Therapeutic Effects of Xianlu Oral Solution on Rats with Oligoasthenozoospermia through Alleviating Apoptosis and Oxidative Stress

Zi-Run Jin; Ya-Lei Cao; Zhi-Chao Luo; Qian-Cheng Zhao; Yu Xi; Jia-Ming Weng; Zhe Zhang; Hui Jiang

doi:10.1155/2022/1269530

Therapeutic Effects of Xianlu Oral Solution on Rats with Oligoasthenozoospermia through Alleviating Apoptosis and Oxidative Stress

Evid Based Complement Alternat Med. 2022 Jun 18:2022:1269530. doi: 10.1155/2022/1269530. eCollection 2022.

Authors

Zi-Run Jin¹, Ya-Lei Cao¹, Zhi-Chao Luo¹, Qian-Cheng Zhao¹, Yu Xi¹, Jia-Ming Weng¹, Zhe Zhang^{1

2}, Hui Jiang^{1

2}

Affiliations

¹ Department of Urology, Peking University Third Hospital, Beijing, China.
² Department of Reproductive Medicine Center, Peking University Third Hospital, Beijing, China.

Abstract

Idiopathic oligoasthenozoospermia (iOAZS) is one of the major causes of male infertility, and the ideal therapies for iOAZS have not been established yet. Traditional Chinese medicine (TCM), including Xianlu oral solution (XL), has been widely used as an adjunct treatment for male infertility in the clinic. However, the underlying mechanisms of XL treatment on iOAZS are still not known. Here, we found that XL treatment has therapeutic effects on ornidazole (ORN)-induced OAZS model rats through the amelioration of testis tissues spermatogenesis and the improvement of sperm concentration and motility. Moreover, XL treatment ameliorated the serum hormone levels, mitochondrial membrane potential, apoptosis status, and oxidative stress status in the testis tissues of iOAZS model rats. These findings identify a potential mechanism underlying the therapeutic effects of Xianlu oral solution on iOAZS, and Xianlu oral solution may be used as a traditional Chinese medicine (TCM) therapy for male infertility caused by iOAZS in clinical practice.